MENU

CYCC Cyclacel Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of mechanism-targeted drugs to treat human cancers

Industry Biotechnology
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CYCC is expected to report earnings to fall 15.65% to -41 cents per share on March 27

Cyclacel Pharmaceuticals CYCC Stock Earnings Reports
Q4'23
Est.
$-0.41
Q3'23
Missed
by $0.13
Q2'23
Beat
by $0.06
Q1'23
Beat
by $0.20
Q4'22
Missed
by $0.12
The last earnings report on November 13 showed earnings per share of -49 cents, missing the estimate of -36 cents. With 199.32K shares outstanding, the current market capitalization sits at 2.15M.
A.I. Advisor
published General Information

General Information

a developer of mechanism-targeted drugs to treat human cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
200 Connell Drive
Phone
+1 908 517-7330
Employees
12
Web
https://cyclacel.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CYCC and Stocks

Correlation & Price change

A.I.dvisor tells us that CYCC and ONPPF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCC and ONPPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCC
1D Price
Change %
CYCC100%
+7.11%
ONPPF - CYCC
23%
Poorly correlated
N/A
BPTSY - CYCC
21%
Poorly correlated
-16.71%
NGENF - CYCC
21%
Poorly correlated
-5.87%
ATNF - CYCC
21%
Poorly correlated
N/A
GNPX - CYCC
21%
Poorly correlated
-2.86%
More